These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8171466)

  • 61. Diabetic nephropathy in insulin-dependent diabetes mellitus patients: how to measure progression of disease and effect of treatment.
    Mogensen CE
    J Diabet Complications; 1991; 5(2-3):65-8. PubMed ID: 1770055
    [No Abstract]   [Full Text] [Related]  

  • 62. Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.
    Feldt-Rasmussen B; Mathiesen ER; Jensen T; Lauritzen T; Deckert T
    Diabetologia; 1991 Mar; 34(3):164-70. PubMed ID: 1884887
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Glucose-controlled insulin infusion systems (GCIIS, artificial pancreas) in therapy of diabetes mellitus and organic hyperinsulinism].
    Sailer D
    Verh Dtsch Ges Inn Med; 1987; 93():309-12. PubMed ID: 3442106
    [No Abstract]   [Full Text] [Related]  

  • 64. [Assessment of insulin resistance in diabetic children].
    Vavrinec J; Lébl J; Zizkovský V; Dvorák P; Snajderová M
    Cesk Pediatr; 1987 May; 42(5):261-5. PubMed ID: 3301013
    [No Abstract]   [Full Text] [Related]  

  • 65. Glomerular charge selectivity and the influence of improved blood glucose control in type 1 (insulin-dependent) diabetic patients with microalbuminuria.
    Bangstad HJ; Kofoed-Enevoldsen A; Dahl-Jørgensen K; Hanssen KF
    Diabetologia; 1992 Dec; 35(12):1165-9. PubMed ID: 1478369
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of moderate dietary protein restriction on the progression of overt diabetic nephropathy: a 6-mo prospective study.
    Raal FJ; Kalk WJ; Lawson M; Esser JD; Buys R; Fourie L; Panz VR
    Am J Clin Nutr; 1994 Oct; 60(4):579-85. PubMed ID: 8092094
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Which patients with diabetes mellitus will get diabetic nephropathy?].
    Gans RO; Bilo HJ
    Ned Tijdschr Geneeskd; 1989 Apr; 133(14):716-20. PubMed ID: 2654658
    [No Abstract]   [Full Text] [Related]  

  • 68. Insulin resistance in type I diabetes: prevalence, pathogenesis and therapeutic approaches.
    Yki-Järvinen H; Koivisto VA
    Ann Clin Res; 1984; 16(2):74-83. PubMed ID: 6380390
    [No Abstract]   [Full Text] [Related]  

  • 69. The glucose sensor. Some results and applications.
    Christensen SE; Schmitz O; Hansen AP; Orskov H
    Acta Med Scand Suppl; 1983; 671():121-8. PubMed ID: 6410697
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Prospective evaluation of the insulin infusion test to establish the adequacy of glucose counterregulation during hypoglycemia in type 1 diabetics undergoing intensive insulin therapy].
    Bolli G; De Feo P; Perriello G; De Cosmo S; Compagnucci P; Ventura MM; Santeusanio F; Gerich JE; Brunetti P
    Minerva Endocrinol; 1984; 9(2):101-5. PubMed ID: 6390121
    [No Abstract]   [Full Text] [Related]  

  • 71. Blood glucose control.
    Uchino H; Kawamori R
    Contrib Nephrol; 2001; (134):106-12. PubMed ID: 11665280
    [No Abstract]   [Full Text] [Related]  

  • 72. [Risk factors associated with the development and clinical progression of diabetic nephropathy].
    Solerte SB; Fioravanti M; Ferrari E
    Minerva Endocrinol; 1988; 13(3):203-14. PubMed ID: 3216830
    [No Abstract]   [Full Text] [Related]  

  • 73. [Type 1 diabetes: long-term effects of intensive insulin therapy on diabetic retinopathy and nephropathy].
    Letonturier P
    Presse Med; 2000 Mar; 29(11):598. PubMed ID: 10776417
    [No Abstract]   [Full Text] [Related]  

  • 74. The quest for normoglycaemia: is it worth the effort?
    Mann JI
    N Z Med J; 1990 Jun; 103(892):292-3. PubMed ID: 2195403
    [No Abstract]   [Full Text] [Related]  

  • 75. Aminaphtone therapy in patients with type 1 diabetes and albuminuria: a case report.
    Romano C; Tamburella C; Costa M; Messina M; Fassari AL; Bertini M
    J Med Case Rep; 2014 Dec; 8():443. PubMed ID: 25524258
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Continuous subcutaneous insulin infusion; the first decade].
    Doorenbos H
    Ned Tijdschr Geneeskd; 1987 Jan; 131(3):91-3. PubMed ID: 3821988
    [No Abstract]   [Full Text] [Related]  

  • 77. ACE inhibitors and diabetic nephropathy.
    Molitch ME
    Diabetes Care; 1994 Jul; 17(7):756-60. PubMed ID: 7924789
    [No Abstract]   [Full Text] [Related]  

  • 78. Does normalization of blood glucose reduce the complications of diabetes?
    Vajdos MA; Gilliland PF
    South Med J; 1995 Mar; 88(3):372-5. PubMed ID: 7886542
    [No Abstract]   [Full Text] [Related]  

  • 79. Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: normalization by insulin-treatment.
    Mogensen CE; Andersen MJ
    Diabetologia; 1975 Jun; 11(3):221-4. PubMed ID: 1149954
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Normoglycemic insulin therapy: benefits and risks].
    Keller U
    Ther Umsch; 1983 Oct; 40(10):852-60. PubMed ID: 6359557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.